Clinical Trial Update: A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating delayed-release pancrelipase for maldigestion in patients with exocrine pancreatic insufficiency due to chronic pancreatitis and after …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Exocrine Insufficiency
• Pancreatitis

Drugs mentioned

• Delayed-release pancrelipase (pancrelipase)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Chronic Pancreatitis, Pancreatectomy | Phase 3 | Status: COMPLETED | Results posted: 2009-09-16